We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SPGI:NYSES&P Global Inc. Analysis

Data as of 2026-03-09 - not real-time

$445.28

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

S&P Global is trading at $445.28, comfortably above its 20‑day SMA (425.7) but still below the 50‑day (484) and 200‑day (506.7) averages, confirming a bearish medium‑term bias. The RSI sits at 47.6, indicating neutral momentum, while the MACD histogram is positive and the MACD signal is flagged as bullish, suggesting a potential short‑term bounce. However, volume is decreasing and the stock faces a strong resistance near $452.7, with support anchored at $381.6. Valuation metrics are stretched: a trailing P/E of 30.4 far exceeds the industry average of 17.4, and the DCF‑derived fair value of $287.5 implies a material discount to the current price. The dividend yield of 0.86% is modest but the payout ratio of 26% appears sustainable given robust operating cash flow of $5.65 B. Recent earnings missed consensus (reported EPS $4.30 vs. $4.33 expected) and the share price fell 9.7%, while analysts trimmed the price target to $482, reflecting heightened short‑term skepticism. The announced spin‑off of the Mobility segment adds structural uncertainty but could ultimately sharpen the company's focus on its high‑margin data and ratings franchise. Despite the valuation gap, the business generates 70% gross margins, 38% operating margins, and a 13% ROE, underscoring a resilient underlying model. With a beta of 0.77 and a 52‑week volatility of 52.6%, the stock exhibits lower market sensitivity but high price swings. Overall, the blend of elevated multiples, recent earnings disappointment, and upcoming corporate restructuring suggests caution in the near term, while the long‑run outlook remains supported by strong cash generation and a defensible market position.
In the medium to long horizon, the company’s solid balance sheet, low payout ratio, and consistent free cash flow position it to weather the spin‑off transition and potentially re‑price toward intrinsic value. Investors should weigh the immediate downside risk against the enduring competitive moat and dividend sustainability when forming a view.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Q4 earnings miss and share price decline
  • Technical bearish bias (price below SMA50/200)
  • Overvaluation relative to DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Spin‑off of Mobility segment may unlock value
  • Strong cash flow and sustainable dividend
  • High profitability margins despite elevated multiples

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable competitive moat in data and ratings
  • Low payout ratio supporting dividend sustainability
  • Potential re‑rating toward intrinsic DCF value

Key Metrics & Analysis

Financial Health

Revenue Growth9.00%
Profit Margin29.15%
P/E Ratio30.4
ROE13.09%
ROA6.66%
Debt/Equity37.91
P/B Ratio4.3
Op. Cash Flow$5.7B
Free Cash Flow$4.9B
Industry P/E17.4

Technical Analysis

TrendBearish
RSI47.6
Support$381.61
Resistance$452.69
MA 20$425.70
MA 50$484.03
MA 200$506.73
MACDBullish
VolumeDecreasing
Fear & Greed Index100

Valuation

Fair Value$287.49
Target Price$537.90
Upside/Downside20.80%
GradeOvervalued
TypeBlend
Dividend Yield0.86%

Risk Assessment

Beta0.77
Volatility52.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.